EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Interferon regulatory factor 4 mediates nonenzymatic IRE1 dependency in multiple myeloma cells

Ioanna Oikonomidi, Vasumathi Kameswaran, Victoria C Pham, Iratxe Zuazo-Gaztelu, Lauren M Gutgesell, Scot Marsters, Bence Daniel, Jennie R Lill, Zora Modrusan, Avi Ashkenazi iD

PLOS Biology · 2025

DOI: 10.1371/journal.pbio.3003096 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Biology, 2025. Verfasst von Ioanna Oikonomidi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research Oncology, Genentech, Inc., South San Francisco, California, United States of America. Hauptthemen laut MEDLINE: Interferon Regulatory Factors, Multiple Myeloma, Protein Serine-Threonine Kinases, Endoribonucleases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple myeloma (MM) arises through oncogenic transformation of immunoglobulin-secreting plasma cells. MM often co-opts the central endoplasmic reticulum (ER)-stress mitigator, inositol-requiring enzyme 1 (IRE1), to sustain malignant growth. While certain MMs require enzymatic IRE1-dependent activation of the transcription factor XBP1s, others display a nonenzymatic IRE1 dependency that is not yet mechanistically understood. Here we identify interferon regulatory factor 4 (IRF4), which stimulates genes that promote immune-cell proliferation, as a key conduit for IRE1’s nonenzymatic control of cell-cycle progression in MM. IRE1 silencing increased inhibitory S114/S270 phosphorylation on IRF4, disrupting IRF4’s chromatin-binding and transcriptional activity. IRF4 knockdown recapitulated, whereas IRF4 repletion reversed, the anti-proliferative phenotype of IRE1 silencing. Furthermore, phospho-deficient, but not phospho-mimetic, IRF4 mutants rescued proliferation under IRE1 silencing. Functional studies revealed that IRF4 engages the E2F1 and CDC25A genes and promotes CDK2 activation to drive cell-cycle progression. Our results advance mechanistic understanding of IRE1 and IRF4 in MM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interferon Regulatory FactorsMultiple MyelomaProtein Serine-Threonine KinasesEndoribonucleasesHumansCell Line, TumorCell ProliferationPhosphorylationGene Expression Regulation, NeoplasticE2F1 Transcription FactorEndoplasmic Reticulum StressCell CycleInterferon Regulatory Factor-4

Substanzen

Interferon Regulatory FactorsProtein Serine-Threonine KinasesEndoribonucleasesE2F1 Transcription FactorInterferon Regulatory Factor-4ERN1 protein, humanE2F1 protein, human

Autor:innen und Institutionen

  • Department of Research Oncology, Genentech, Inc., South San Francisco, California, United States of America.
  • Department of Proteomic and Genomic Technologies, Genentech, Inc., South San Francisco, California, United States of America.

ORCID-Profile: Avi Ashkenazi

Zitieren

APA

Oikonomidi, I., Kameswaran, V., Pham, V. C., Zuazo-Gaztelu, I., Gutgesell, L. M., Marsters, S., Daniel, B., Lill, J. R., Modrusan, Z., & Ashkenazi, A. (2025). Interferon regulatory factor 4 mediates nonenzymatic IRE1 dependency in multiple myeloma cells. PLOS Biology. https://doi.org/10.1371/journal.pbio.3003096

Vancouver

Oikonomidi I, Kameswaran V, Pham VC, Zuazo-Gaztelu I, Gutgesell LM, Marsters S, et al. Interferon regulatory factor 4 mediates nonenzymatic IRE1 dependency in multiple myeloma cells. PLOS Biology. 2025. doi:10.1371/journal.pbio.3003096

BibTeX
@article{Oikonomidi2025,
  author = {Oikonomidi, Ioanna and Kameswaran, Vasumathi and Pham, Victoria C and Zuazo-Gaztelu, Iratxe and Gutgesell, Lauren M and Marsters, Scot and Daniel, Bence and Lill, Jennie R and Modrusan, Zora and Ashkenazi, Avi},
  title = {Interferon regulatory factor 4 mediates nonenzymatic IRE1 dependency in multiple myeloma cells},
  journal = {PLOS Biology},
  year = {2025},
  doi = {10.1371/journal.pbio.3003096}
}
Kostenlos starten →